These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 35202494

  • 21. Congenital dopamine-beta-hydroxylase deficiency in humans.
    Timmers HJ, Deinum J, Wevers RA, Lenders JW.
    Ann N Y Acad Sci; 2004 Jun; 1018():520-3. PubMed ID: 15240410
    [Abstract] [Full Text] [Related]

  • 22. Autonomic dysfunction: diagnosis guided by therapy.
    Robertson RM, Biaggioni I, Mosqueda-Garcia R, Robertson D.
    Trans Am Clin Climatol Assoc; 1992 Jun; 103():228-37. PubMed ID: 1413383
    [No Abstract] [Full Text] [Related]

  • 23. Droxidopa in neurogenic orthostatic hypotension.
    Kaufmann H, Norcliffe-Kaufmann L, Palma JA.
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(8):875-91. PubMed ID: 26092297
    [Abstract] [Full Text] [Related]

  • 24. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.
    Mathias CJ.
    Clin Auton Res; 2008 Mar; 18 Suppl 1():25-9. PubMed ID: 18368304
    [Abstract] [Full Text] [Related]

  • 25.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Biaggioni I.
    ; 1993 Mar. PubMed ID: 20301647
    [Abstract] [Full Text] [Related]

  • 26. [A case of diabetic orthostatic hypotension effectively managed with L-dops (L-threo-3,4-dihydroxyphenylserine)].
    Yoshikawa H, Kawai K, Inoue S, Murayama Y, Kuzuya N, Fujita T, Koide Y, Yamashita K, Yoshizawa K, Mizusawa H.
    Nihon Naika Gakkai Zasshi; 1987 Nov; 76(11):1695-700. PubMed ID: 3151075
    [No Abstract] [Full Text] [Related]

  • 27. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions.
    Loavenbruck A, Sandroni P.
    Curr Med Res Opin; 2015 Nov; 31(11):2095-104. PubMed ID: 26373628
    [Abstract] [Full Text] [Related]

  • 28. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R.
    Circulation; 2003 Aug 12; 108(6):724-8. PubMed ID: 12885750
    [Abstract] [Full Text] [Related]

  • 29. DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa.
    Despas F, Pathak A, Berry M, Cagnac R, Massabuau P, Liozon E, Galinier M, Senard JM.
    Clin Auton Res; 2010 Jun 12; 20(3):205-7. PubMed ID: 20063034
    [Abstract] [Full Text] [Related]

  • 30. Effect of L-threo-3, 4-dihydroxyphenylserine on orthostatic hypotension in a patient with spinal cord injury.
    Muneta S, Iwata T, Hiwada K, Murakami E, Sato Y, Imamura Y.
    Jpn Circ J; 1992 Mar 12; 56(3):243-7. PubMed ID: 1552652
    [Abstract] [Full Text] [Related]

  • 31. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
    Carvalho MJ, van den Meiracker AH, Boomsma F, Man in 't Veld AJ, Freitas J, Costa O, de Freitas AF.
    J Auton Nerv Syst; 1997 Jan 12; 62(1-2):63-71. PubMed ID: 9021651
    [Abstract] [Full Text] [Related]

  • 32. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension.
    Keating GM.
    Drugs; 2015 Feb 12; 75(2):197-206. PubMed ID: 25559422
    [Abstract] [Full Text] [Related]

  • 33. Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
    Akizawa T, Koshikawa S, Iida N, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M, Tubakihara Y.
    Nephron; 2002 Apr 12; 90(4):384-90. PubMed ID: 11961396
    [Abstract] [Full Text] [Related]

  • 34. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
    Birkmayer W, Birkmayer G, Lechner H, Riederer P.
    J Neural Transm; 1983 Apr 12; 58(3-4):305-13. PubMed ID: 6420517
    [Abstract] [Full Text] [Related]

  • 35. Sleeping with and without norepinephrine: effects of metoclopramide and D,L-threo-3,4-dihydroxyphenylserine on sleep in dopamine beta-hydroxylase deficiency.
    Tulen JH, Man in 't Veld AJ, Dzoljic MR, Mechelse K, Moleman P.
    Sleep; 1991 Feb 12; 14(1):32-8. PubMed ID: 1811317
    [Abstract] [Full Text] [Related]

  • 36. Pediatric ptosis as a sign of treatable autonomic dysfunction.
    Phillips L, Robertson D, Melson MR, Garland EM, Joos KM.
    Am J Ophthalmol; 2013 Aug 12; 156(2):370-374.e2. PubMed ID: 23622564
    [Abstract] [Full Text] [Related]

  • 37. [Development of L-threo-DOPS, a norepinephrine precursor amino acid].
    Katsube J, Narabayashi H, Hayashi A, Tanaka C, Suzuki T.
    Yakugaku Zasshi; 1994 Nov 12; 114(11):823-46. PubMed ID: 7853146
    [Abstract] [Full Text] [Related]

  • 38. Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome.
    Man in 't Veld AJ, Boomsma F, Moleman P, Schalekamp MA.
    Lancet; 1987 Jan 24; 1(8526):183-8. PubMed ID: 2880016
    [Abstract] [Full Text] [Related]

  • 39. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
    Senda Y, Muto T, Matsuoka Y, Takahashi A, Sobue I.
    Rinsho Shinkeigaku; 1987 Mar 24; 27(3):300-4. PubMed ID: 3111772
    [No Abstract] [Full Text] [Related]

  • 40. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
    Hoeldtke RD, Cilmi KM, Mattis-Graves K.
    Clin Pharmacol Ther; 1984 Sep 24; 36(3):302-6. PubMed ID: 6432398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.